Edwards Lifesciences Corp

NYSE:EWUnited States

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. It conducts operations worldwide and is managed in various geographical regions, including the United States, Europe, Japan, and Rest of World. It sells products that are used to treat advanced cardiovascular disease in all regions.

Contact Information

Headquarters

One Edwards WayIRVINE, CA, United States 92614

Phone

949-250-2500

Fax

302-655-5049

Executives

Non-Executive Chairman of the Board

Michael Mussallem

President

Bernard Zovighian

Chief Financial Officer, Corporate Vice President

Scott Ullem

Senior Vice President, General Manager - Surgical Structural Heart

Wayne Markowitz

Corporate Vice President - Strategy and Corporate Development

Donald Bobo